• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由4F2抗原(CD98)重链激活的大中性氨基酸转运体的表达克隆与特性分析

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).

作者信息

Kanai Y, Segawa H, Miyamoto K i, Uchino H, Takeda E, Endou H

机构信息

Department of Pharmacology and Toxicology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181, Japan.

出版信息

J Biol Chem. 1998 Sep 11;273(37):23629-32. doi: 10.1074/jbc.273.37.23629.

DOI:10.1074/jbc.273.37.23629
PMID:9726963
Abstract

A cDNA was isolated from rat C6 glioma cells by expression cloning which encodes a novel Na+-independent neutral amino acid transporter designated LAT1. For functional expression in Xenopus oocytes, LAT1 required the heavy chain of 4F2 cell surface antigen (CD98), a type II membrane glycoprotein. When co-expressed with 4F2 heavy chain, LAT1 transported neutral amino acids with branched or aromatic side chains and did not accept basic amino acids or acidic amino acids. The transport via LAT1 was Na+-independent and sensitive to a system L-specific inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid. These functional properties correspond to those of the classically characterized amino acid transport system L, a major nutrient transporter. In in vitro translation, LAT1 was shown to be a nonglycosylated membrane protein consistent with the property of 4F2 light chain, suggesting LAT1 is at least one of the proteins formerly referred to as 4F2 light chain. LAT1 exhibits relatively low but significant amino acid sequence similarity to mammalian cationic amino acid transporters and amino acid permeases of bacteria and yeasts, indicating LAT1 is a new member of the APC superfamily. Because of highly regulated nature and high level of expression in tumor cell lines, LAT1 is thought to be up-regulated to support the high protein synthesis for cell growth and cell activation. The cloning of LAT1 is expected to facilitate the research on the protein-protein interaction in the transporter field and to provide a clue to the search for still unidentified transporters.

摘要

通过表达克隆从大鼠C6胶质瘤细胞中分离出一种互补DNA(cDNA),其编码一种名为LAT1的新型非钠依赖性中性氨基酸转运体。为了在非洲爪蟾卵母细胞中进行功能性表达,LAT1需要4F2细胞表面抗原(CD98)的重链,这是一种II型膜糖蛋白。当与4F2重链共表达时,LAT1转运带有支链或芳香族侧链的中性氨基酸,不接受碱性氨基酸或酸性氨基酸。通过LAT1的转运不依赖于钠,且对系统L特异性抑制剂2-氨基双环-(2,2,1)-庚烷-2-羧酸敏感。这些功能特性与经典表征的氨基酸转运系统L(一种主要的营养转运体)的特性相符。在体外翻译中,LAT1被证明是一种非糖基化膜蛋白,这与4F2轻链的特性一致,表明LAT1至少是以前被称为4F2轻链的蛋白质之一。LAT1与哺乳动物阳离子氨基酸转运体以及细菌和酵母的氨基酸通透酶表现出相对较低但显著的氨基酸序列相似性,表明LAT1是APC超家族的一个新成员。由于其高度受调控的性质以及在肿瘤细胞系中的高表达水平,LAT1被认为是上调的,以支持细胞生长和细胞激活所需的高蛋白合成。LAT1的克隆有望促进转运体领域蛋白质 - 蛋白质相互作用的研究,并为寻找仍未鉴定的转运体提供线索。

相似文献

1
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).由4F2抗原(CD98)重链激活的大中性氨基酸转运体的表达克隆与特性分析
J Biol Chem. 1998 Sep 11;273(37):23629-32. doi: 10.1074/jbc.273.37.23629.
2
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.一种具有广泛底物选择性的非Na⁺依赖性中性氨基酸转运体的鉴定及功能表征。
J Biol Chem. 1999 Jul 9;274(28):19745-51. doi: 10.1074/jbc.274.28.19745.
3
Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria.一种与4F2hc而非rBAT形成异源二聚体发挥作用的b(0, +)样氨基酸转运体的克隆与表达。胱氨酸尿症的一个新候选基因。
J Biol Chem. 1999 Oct 8;274(41):29005-10. doi: 10.1074/jbc.274.41.29005.
4
The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: evidence from expression studies in Xenopus laevis oocytes.4F2hc表面抗原对于C6-BU-1大鼠胶质瘤细胞中L-型中性氨基酸转运活性的表达是必需的:来自非洲爪蟾卵母细胞表达研究的证据。
Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):863-70. doi: 10.1042/bj3120863.
5
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.人类L型氨基酸转运体1(LAT1):肿瘤细胞系中的功能及表达特性
Biochim Biophys Acta. 2001 Oct 1;1514(2):291-302. doi: 10.1016/s0005-2736(01)00384-4.
6
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.鉴定出一种膜蛋白LAT-2,它与4F2重链共表达,具有对两性离子型小氨基酸和大氨基酸具有广泛特异性的L型氨基酸转运活性。
J Biol Chem. 1999 Jul 9;274(28):19738-44. doi: 10.1074/jbc.274.28.19738.
7
Transport properties of a system y+L neutral and basic amino acid transporter. Insights into the mechanisms of substrate recognition.系统y+L中性和碱性氨基酸转运体的转运特性。对底物识别机制的深入了解。
J Biol Chem. 2000 Jul 7;275(27):20787-93. doi: 10.1074/jbc.M000634200.
8
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.4F2hc/CD98异二聚体与糖蛋白相关氨基酸转运体家族成员介导的y+L型氨基酸转运
EMBO J. 1999 Jan 4;18(1):49-57. doi: 10.1093/emboj/18.1.49.
9
Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids.一种与4F2重链相关联、对中性D-和L-氨基酸小分子具有底物选择性的非Na⁺依赖性中性氨基酸转运体的鉴定与表征。
J Biol Chem. 2000 Mar 31;275(13):9690-8. doi: 10.1074/jbc.275.13.9690.
10
The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1.异二聚体氨基酸转运体4F2hc/LAT1在非洲爪蟾卵母细胞中与一种受丝氨酸/苏氨酸激酶sgk-1调控的非选择性阳离子通道相关联。
J Physiol. 2000 Jul 1;526 Pt 1(Pt 1):35-46. doi: 10.1111/j.1469-7793.2000.00035.x.

引用本文的文献

1
A Novel Approach for Cisplatin-Resistant Esophageal Squamous Cell Carcinoma via Amino Acid Transporter LAT1 Inhibition.通过抑制氨基酸转运体LAT1治疗顺铂耐药食管鳞状细胞癌的新方法。
Cancer Med. 2025 Sep;14(17):e71234. doi: 10.1002/cam4.71234.
2
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review).L型氨基酸转运体1在增强硼中子俘获治疗中的作用:机制、挑战与未来方向(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5611. Epub 2025 Aug 24.
3
Targeting SLC7A5 in lung squamous cell carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistance.
靶向肺鳞状细胞癌中的SLC7A5:对癌症代谢转变和硼中子俘获治疗耐药性的影响
Oncogenesis. 2025 Jul 23;14(1):26. doi: 10.1038/s41389-025-00568-z.
4
Construction of a glycolysis-related diagnostic model for osteoarthritis through integrated bioinformatics analysis and machine learning.通过综合生物信息学分析和机器学习构建骨关节炎的糖酵解相关诊断模型
J Orthop Surg Res. 2025 Jul 11;20(1):639. doi: 10.1186/s13018-025-06072-9.
5
The role of NAD metabolism and its modulation of mitochondria in aging and disease.NAD代谢及其对线粒体的调节在衰老和疾病中的作用。
NPJ Metab Health Dis. 2025 Jun 18;3(1):26. doi: 10.1038/s44324-025-00067-0.
6
L-3-[F]-Fluoro-α-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical Applications.L-3-[F]-氟-α-甲基酪氨酸作为肿瘤诊断的正电子发射断层显像(PET)示踪剂:从机制到临床应用的系统评价
Int J Mol Sci. 2025 Jun 18;26(12):5848. doi: 10.3390/ijms26125848.
7
Targeting LAT1 with JPH203 to reduce TNBC proliferation and reshape suppressive immune microenvironment by blocking essential amino acid uptake.用JPH203靶向LAT1,通过阻断必需氨基酸摄取来减少三阴性乳腺癌的增殖并重塑抑制性免疫微环境。
Amino Acids. 2025 May 17;57(1):27. doi: 10.1007/s00726-025-03456-3.
8
Lentivirus-Mediated Trophoblast-Specific Deptor Knockdown Increases Transplacental System A and System L Amino Acid Transport and Fetal Growth in Mice.慢病毒介导的滋养层特异性Deptor基因敲低增加小鼠经胎盘系统A和系统L氨基酸转运及胎儿生长
Function (Oxf). 2025 Mar 24;6(2). doi: 10.1093/function/zqaf018.
9
Structural basis for the substrate recognition and transport mechanism of the human yLAT1-4F2hc transporter complex.人源yLAT1-4F2hc转运蛋白复合物底物识别与转运机制的结构基础
Sci Adv. 2025 Mar 21;11(12):eadq0558. doi: 10.1126/sciadv.adq0558. Epub 2025 Mar 19.
10
Structural basis of anticancer drug recognition and amino acid transport by LAT1.LAT1识别抗癌药物及转运氨基酸的结构基础
Nat Commun. 2025 Feb 14;16(1):1635. doi: 10.1038/s41467-025-56903-w.